ArticleFrontiers in microbiology2026
Clinical characteristics and risk factors of
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: The clinical data of 430 patients with SA-BSI in the First Affiliated Hospital of Bengbu Medical University from January 2013 to October 2024 were analyzed retrospectively. Univariate and multivariate logistic regression analysis was used to analyze the risk factors of poor prognosis. Results: Among the 430 cases of SA-BSI, the isolation rate of MRSA was 50.47% (217/430) and the incidence of poor prognosis was 18.14% (78/430). The rates of admission to ICU, respiratory failure, central venous catheterization, endotracheal intubation, urinary catheter, tracheotomy and non-invasive mechanical ventilation in MRSA group were significantly higher than those in MSSA group ( Conclusion: Patients with respiratory failure, ICU admission, or indwelling catheters are at increased risk for MRSA bloodstream infection, while respiratory failure, septic shock, high Pitt bacteremia score, and elevated procalcitonin may worsen prognosis of patients with SA-BSI. To improve outcomes, clinicians should implement targeted interventions, including enhanced screening and contact precautions for high-risk patients, judicious management of invasive devices, and antimicrobial stewardship with early source control. Strengthening risk assessment and these measures can optimize SA-BSI management and patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.